Objective To evaluate the pancreaticojejunostomy procedures selection strategy in pancreaticoduodenectomy.

Methods The clinical data of 455 patients who received pancreaticoduodenectomy at the Xijing Hospital from June 2007 to June 2012 were retrospectively analyzed. For patients with pancreatic duct diameter≥4 mm, duct-to-mucosa pancreaticojejunostomy (DMPJ) was applied (DMPJ group, 210 cases). For patients with pancreatic duct diameter<4 mm, modified Child pancreaticojejunostomy was applied  to 140 patients (modified Child group) whose jejunal end was smaller than the pancreatic stump, and binding pancreaticojejunostomy was applied to 105 patients (binding group) whose jejunal end was bigger than or equal to the pancreatic stump. The clinical efficacy and incidence of postoperative complications were compared among the 3 groups. The count data and measurement data were analyzed by chi-square test and t  test, respectively.

Results The pancreatic duct diameter of the DMPJ group was (4.4±0.7)mm, which was significantly bigger than (2.8±0.6)mm of the modified Child group and (2.3±0.7)mm of the binding group (t=2.25, 2.48, P<0.05). The diameter of the pancreatic stump of the modified Child group was (36±5)mm, which was significantly bigger than (21±6)mm of the binding group (t=21.65, P<0.05). The overall incidence of pancreatic leakage was 8.4%(38/455). There were no significant differences in the incidences of pancreatic leakage, peritoneal bleeding, abdominal infection, digestive dysfunction rate and the mean duration of hospital stay among the 3 groups (χ2=0.53, 0.88, 1.63, 5.34, F=2.53, P>0.05).

Conclusion Pancreaticojejunostomy procedure selection strategy based on the diameters of pancreatic duct and pancreatic stump could obtain good clinical efficacy and is appropriate.